Actively Recruiting
TEXT4HF: A Randomized Controlled Trial of a Tailored Text Messaging Intervention to Improve Self-Care in Older Adult Patients With Heart Failure
Led by University of Illinois at Chicago · Updated on 2025-09-11
30
Participants Needed
1
Research Sites
91 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to determine whether an individually tailored text messaging intervention can improve self-care in older adult patients with heart failure. The main question it aims to answer are: * Is a tailored text messaging intervention feasible and acceptable among older adult patients with heart failure? * Does tailored text messaging improve self-care in adult patients with heart failure? Participants will be randomly assigned to one of two groups for 12 weeks: 1) intervention (text messaging); or 2) control group. Both groups will receive usual care, which includes regular follow-up visits at the heart failure clinic (standard care), plus a "Discharge Packet for Patients Diagnosed with Heart Failure", developed by the American Heart Association. Both groups will be asked via text messages and/or telephone calls to complete questionnaires at baseline/start, 4 weeks and 12 weeks, about self-care, quality of life, health beliefs, medications, diet, etc. Participants assigned to the intervention group will also receive approximately 5 text messages/week targeting medication adherence, heart-healthy diet, and self-monitoring for 12 weeks.
CONDITIONS
Official Title
TEXT4HF: A Randomized Controlled Trial of a Tailored Text Messaging Intervention to Improve Self-Care in Older Adult Patients With Heart Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 50 years of age or older
- Diagnosed with heart failure Stage C, NYHA Class I-IV and currently on a loop diuretic
- Own a mobile phone with a text message plan
- Ability to speak and read English
- Suboptimal heart failure self-care, with a SCHFI score of 3 or less in at least two self-care areas (maintenance, symptom perception, or self-management)
You will not qualify if you...
- Scheduled for SAVR/TAVR, Ventricular Assist Device, Cardiac Resynchronization Therapy implantation, or heart transplantation within the next 3 months
- Had coronary revascularization or CRT implantation within the past 30 days
- Diagnosed with psychosis
- Receiving hospice or end-of-life care
- Advanced renal disease with estimated glomerular filtration rate below 25 or on hemodialysis
- Cognitive impairment such as dementia or Alzheimer's disease
- Unable to self-manage daily activities like taking medications, bathing, or using the toilet
- Currently living in a nursing home
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Illinois, Chicago
Chicago, Illinois, United States, 60612
Actively Recruiting
Research Team
J
Jonathan W Leigh, MPH, MSHI
CONTACT
S
Spyros Kitsiou, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here